Aurora will supply the French Expert Network for the Diagnosis of Rare Otolaryngology (ENT) Cancers (REFCOR) for their medical multi-disciplinary team meetings (MDTMs) and their case reviews by the national pathology expert panel

MONTREAL (CANADA), December 22, 2011 - Aurora Interactive Ltd., the world leader in digital pathology communications, announced today that the company has signed a contract for the supply of its mScope clinical communications platform following a request for proposal from the REFCOR group for the establishment of a national telepathology network to implement: information sharing; case management; and the viewing and analysis of diagnostic pathology images. The system allows for remote diagnostics and collaboration among expert pathologists and clinicians.

"REFCOR’s goal is to improve the management of treatment for patients with rare head and neck cancers including those of the paranasal sinuses, salivary glands, ears and rare cancers of the upper aerodigestive tract. The mScope network will provide us with a communication tool for the submission of cases to the national MDTM or the national pathology expert panel,” said Dr. François Janot of the Gustave Roussy Cancer Institute.

Pierre Le Fevre, President and CEO of Aurora Interactive, said: "We are very proud to have won this contract and to have earned the trust of the REFCOR group's leaders and their partners in this project. We are also very pleased to partner with a project that is at the forefront of the use of digital pathology to advance the science relating to rare head and neck cancers.”

About Aurora Interactive

Aurora Interactive has developed the leading Web-based software platform (mScope) for simplification, productivity and ease of pathology communications.  mScope’s Universal Web Viewer has collaborative tools to view medical slides and images anytime, anywhere, regardless of file format.  The software has four applications to aid digital pathology web based communications needs: mScope Education, mScope Clinical, mScope Research and mScope Universal Viewer. Aurora’s mission is to improve patient outcomes and help members of the medical community achieve their full potential by eliminating the learning, diagnostic and collaborative restrictions imposed by time and space. http://www.aurorainteractive.com  
 

The French Rare Head and Neck Cancer Expert Network (REFCOR)

Created in 2008 under the patronage of the Société Française ORL (French Society of Otolaryngology), REFCOR’s objective is the improved management of medical treatment for patients with rare head and neck cancers. The first four objectives of REFCOR are: The publication of reference national recommendations on the four main types of rare head and neck cancers; The creation of a national database referencing cases and incorporating epidemiological, clinical and anatomic and cytopathology data; The establishment of reference centres including the ability to coordinate medical multi-disciplinary team meetings to review "rare head and neck cancers" at the regional level while providing an efficient network for national collaboration; and the organizing of tumor banks / serum banks / tissue banks, the standardization of methods for the collection and systematic storage of samples taken from targeted patients. REFCOR currently organizes national MDTMs for the most difficult cases and a system of case review by pathologists specializing in  these cancers.